BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26385923)

  • 1. Structural Insights into mitochondrial antiviral signaling protein (MAVS)-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling.
    Shi Z; Zhang Z; Zhang Z; Wang Y; Li C; Wang X; He F; Sun L; Jiao S; Shi W; Zhou Z
    J Biol Chem; 2015 Oct; 290(44):26811-20. PubMed ID: 26385923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
    Zhang X; Zhu C; Wang T; Jiang H; Ren Y; Zhang Q; Wu K; Liu F; Liu Y; Wu J
    PLoS Pathog; 2017 Apr; 13(4):e1006321. PubMed ID: 28394926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP11 disrupts MAVS signalosome to inhibit type I interferon signaling and virus-induced apoptosis.
    Qin Y; Su Z; Wu Y; Wu C; Jin S; Xie W; Jiang W; Zhou R; Cui J
    EMBO Rep; 2017 Dec; 18(12):2160-2171. PubMed ID: 29097393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling.
    Koshiba T; Yasukawa K; Yanagi Y; Kawabata S
    Sci Signal; 2011 Feb; 4(158):ra7. PubMed ID: 21285412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitofusin 2 inhibits mitochondrial antiviral signaling.
    Yasukawa K; Oshiumi H; Takeda M; Ishihara N; Yanagi Y; Seya T; Kawabata S; Koshiba T
    Sci Signal; 2009 Aug; 2(84):ra47. PubMed ID: 19690333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades.
    Liu S; Chen J; Cai X; Wu J; Chen X; Wu YT; Sun L; Chen ZJ
    Elife; 2013 Aug; 2():e00785. PubMed ID: 23951545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response.
    Paz S; Vilasco M; Werden SJ; Arguello M; Joseph-Pillai D; Zhao T; Nguyen TL; Sun Q; Meurs EF; Lin R; Hiscott J
    Cell Res; 2011 Jun; 21(6):895-910. PubMed ID: 21200404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria-nucleus shuttling FK506-binding protein 51 interacts with TRAF proteins and facilitates the RIG-I-like receptor-mediated expression of type I IFN.
    Akiyama T; Shiraishi T; Qin J; Konno H; Akiyama N; Shinzawa M; Miyauchi M; Takizawa N; Yanai H; Ohashi H; Miyamoto-Sato E; Yanagawa H; Yong W; Shou W; Inoue J
    PLoS One; 2014; 9(5):e95992. PubMed ID: 24788966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Innate Immune Signalling by Lipid-Mediated MAVS Transmembrane Domain Oligomerization.
    Nobre L; Wise D; Ron D; Volmer R
    PLoS One; 2015; 10(8):e0136883. PubMed ID: 26317833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TLR signaling adaptor TRAM interacts with TRAF6 to mediate activation of the inflammatory response by TLR4.
    Verstak B; Stack J; Ve T; Mangan M; Hjerrild K; Jeon J; Stahl R; Latz E; Gay N; Kobe B; Bowie AG; Mansell A
    J Leukoc Biol; 2014 Sep; 96(3):427-36. PubMed ID: 24812060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and Enhanced Binding between Key Immunity Proteins TRAF6 and TIFA.
    Huang WC; Liao JH; Hsiao TC; Wei TW; Maestre-Reyna M; Bessho Y; Tsai MD
    Chembiochem; 2019 Jan; 20(2):140-146. PubMed ID: 30378729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the prion-like MAVS filaments in antiviral innate immunity.
    Xu H; He X; Zheng H; Huang LJ; Hou F; Yu Z; de la Cruz MJ; Borkowski B; Zhang X; Chen ZJ; Jiang QX
    Elife; 2014 Jan; 3():e01489. PubMed ID: 24569476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of RIG-I-Mediated Antiviral Signaling Triggers Autophagy Through the MAVS-TRAF6-Beclin-1 Signaling Axis.
    Lee NR; Ban J; Lee NJ; Yi CM; Choi JY; Kim H; Lee JK; Seong J; Cho NH; Jung JU; Inn KS
    Front Immunol; 2018; 9():2096. PubMed ID: 30258449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DEAH-box RNA helicase DHX15 activates NF-κB and MAPK signaling downstream of MAVS during antiviral responses.
    Mosallanejad K; Sekine Y; Ishikura-Kinoshita S; Kumagai K; Nagano T; Matsuzawa A; Takeda K; Naguro I; Ichijo H
    Sci Signal; 2014 Apr; 7(323):ra40. PubMed ID: 24782566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response.
    Hou F; Sun L; Zheng H; Skaug B; Jiang QX; Chen ZJ
    Cell; 2011 Aug; 146(3):448-61. PubMed ID: 21782231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of domains of IPS-1 using an inducible oligomerization system.
    Takamatsu S; Onoguchi K; Onomoto K; Narita R; Takahasi K; Ishidate F; Fujiwara TK; Yoneyama M; Kato H; Fujita T
    PLoS One; 2013; 8(1):e53578. PubMed ID: 23308256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
    Xiao X; Fu Y; You W; Huang C; Zeng F; Gu X; Sun X; Li J; Zhang Q; Du W; Cheng G; Liu Z; Liu L
    J Virol; 2024 May; 98(5):e0157323. PubMed ID: 38572974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2.
    Qin Y; Xue B; Liu C; Wang X; Tian R; Xie Q; Guo M; Li G; Yang D; Zhu H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPM1A silences cytosolic RNA sensing and antiviral defense through direct dephosphorylation of MAVS and TBK1.
    Xiang W; Zhang Q; Lin X; Wu S; Zhou Y; Meng F; Fan Y; Shen T; Xiao M; Xia Z; Zou J; Feng XH; Xu P
    Sci Adv; 2016 Jul; 2(7):e1501889. PubMed ID: 27419230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of OTUD1 by RNA viruses potently inhibits innate immune responses by promoting degradation of the MAVS/TRAF3/TRAF6 signalosome.
    Zhang L; Liu J; Qian L; Feng Q; Wang X; Yuan Y; Zuo Y; Cheng Q; Miao Y; Guo T; Zheng X; Zheng H
    PLoS Pathog; 2018 May; 14(5):e1007067. PubMed ID: 29734366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.